Combining NMR Spectral Information with Associated Structural Features to Form Computationally Nonintensive, Rugged, and Objective Models of Biological Activity

Drug Discovery Handbook

Volumn , Issue , 2005, Pages 227-286

  Beger, Richard D ^a   Buzatu, Dan A ^a   Wilkes, Jon G ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Enthalpy and entropy effects evaluation; Quantitative spectrometric data activity relationships (QSDARs); Quantitative structure activity relationship (QSAR)

Indexed keywords

EID: 84889804431     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0471728780.ch6     Document Type: Chapter

References (68)

1. Cramer, R. D., Bunce, J. D., Patterson, D. E. (1988). Cross-validation, bootstrapping, and partial least squares compared with multiple regression in conventional QSAR studies. Quant. Struct. Act. Relat., 7, 18-25.
2. Cramer, R. D., Paterson, D. E., Bunce, J. D. (1988). Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc., 110, 5959-5967.
3. Klopman, G. (1984). Artificial intelligence approach to structure-activity studies. Computer automated structure evaluation of biological activity of organic molecules. J. Am. Chem. Soc., 106, 7315-7321.
4. Klopman, G. (1992). MULTICASE1. A hierarchial computer automated structure evaluation program. Quant. Struct. Act. Rel., 11, 176-184.
5. Hansch, C., Leo, A. (1995). Exploring QSAR-Fundamentals and Applications in Chemistry and Biology. American Chemical Society,Washington DC.
6. Tong,W., Perkins, R., Xing, L.,Welsh,W. J., Sheehan, D. M. (1997). QSAR models for binding of estrogenic compounds to estrogen receptor a and b subtypes. Endocrinology, 138, 4022-4025.
7. Oprea, T. I., Garcia, A. E. (1996). Three-dimensional quantitative structure-activity relationships of steroid aromatase inhibitors. J. Comput. Aid. Mol. Des., 10, 186-200.
8. Shi, L. M., Fang, H.,Tong,W.,Wu, J., Perkins, R., Blair, R. M., Branham,W. S.,Dial, S. L., Moland, C. L., D. M. Sheehan, D. M. (2001). QSAR models using a large diverse set of estrogens. J. Chem. Inf. Comput. Sci., 41, 186-195.
9. Katritzky, A. R., Mu, L., Labanov,V. S., Karelson, M. (1996). Correlation of boiling points with molecular structure. 1. A training set of 298 diverse organics and a test set of 9 simple inorganics. J. Phys. Chem., 100, 10400-10407.
10. Fujita,T., Iwasa, J., Hansch, C. (1964). A new substituent constant, p, derived from partition coefficient. J. Am. Chem. Soc., 86, 5175-5180.
11. Branbury, S. P. (1995). Quantitative structure-activity relationship and ecological risk assessment:An overview of predictive aquatic toxicology research. Toxicology, 25, 67-89.
12. De Dios,A. C., Pearson, J. G., Oldfield, E. (1993). Secondary and tertiary structural effects on protein NMR chemical shifts: An ab initio approach. Science, 260, 1491-1496.
13. Emsley, J.W., Feeney, J., Sutcliffe, L. H. (1965). High Resolution Nuclear Magnetic Resonance, Vol. I. Pergamon, Oxford, pp. 1-287.
14. Beger, R. D., Freeman, J., Lay Jr., J.,Wilkes, J., Miller, D.W. (2000). 13C NMR and EI mass spectrometric data-activity relationship (SDAR) model of estrogen receptor binding. Toxicol. Appl. Pharmacol., 169, 17-25.
15. Beger, R. D., Bolton, P. H. (1997). Protein f and y dihedral restraints determined from multidimensional hypersurface correlations of backbone chemical shifts and their use in the determination of protein tertiary structures. J. Biomol. NMR, 10, 129-142.
16. Wishart, D. S., Sykes B. D. (1994). Chemical shifts as a tool for structure determination. Methods Enzymol., 239, 363-392.
17. Lefebvre B.,Williams, A. (2003). 13C NMR chemical shift prediction: A comparison of methods and a case study analysis of Paclitaxel (TAXOL®). Poster presentation, 44th ENC.
18. Meiler, J., Meusinger, R., Will, M. (2000). Fast determination of 13 C NMR chemical shifts using artificial neural networks. J. Chem. Inf. Comp. Sci., 40, 1169-1176.
19. Kvasnicka, V. (1991). An application of neural networks in chemistry. Prediction of 13C NMR chemical shifts. J. Math. Chem., 6, 63-76.
20. Shade, L., Beger, R. D.,Wilkes. J. G. (2003). New computerized method for modeling binding affinities to the aryl hydrocarbon receptor using 13C NMR spectra. Environ. Toxicol. Chem., 22, 501-509.
21. Beger, R. D., Freeman, J., Lay Jr., J. O.,Wilkes, J. G., Miller, D.W. (2000). Producing 13C NMR, infrared absorption and EI mass spectrometric data models of the monodechlorination of chlorobenzenes, chlorophenols, and chloroanilines. J. Chem. Inf. Comput. Sci., 40, 1449-1455.
22. Beger, R. D.,Wilkes, J. G. (2001). Developing 13C NMR quantitative spectrometric data-activity relationship (QSDAR) models of steroid binding to the corticosteroid binding globulin. J. Comput. Aid. Mol. Des., 15, 659-669.
23. Beger, R. D., Wilkes, J. G. (2001). 13C NMR quantitative spectrometric dataactivity relationship (QSDAR) models to the aromatase enzyme. J. Chem. Inf. Comput. Sci., 41, 1360-1366.
24. Beger,R. D.,Wilkes, J. G. (2001). Models of polychlorinated dibenzodioxins, dibenzofurans, and biphenyls binding affinity to the aryl hydrocarbon receptor developed using 13C NMR data. J. Chem. Inf. Comput. Sci., 41, 1322-1329.
25. Bax,A., Grzesiek, S. (1993). Methodological advances in protein NMR. Acc. Chem. Res., 26, 131-138.
26. Aue,W. P., Bartholdi, E., Ernst, R. R. (1976). Two-dimensional spectroscopy. Application to nuclear magnetic resonance. J. Chem. Phys., 64, 2229-2246.
27. Bodenhausen, G., Ruben, D. J. (1980). Natural abundance nitrogen-15 NMR by enhanced heteronuclear spectroscopy. Chem. Phys. Lett., 69, 185-189.
28. Bax, A., Griffey, R. H., Hawkins, B. L. (1983). Sensitivity-enhanced correlation of 15N and 1H chemical shifts in natural-abundance samples via multiple quantum coherence. J. Am. Chem. Soc., 105, 7188-7190.
29. Bax, A., Summers,M. F. (1986). 1H and 13C Assignments from sensitivity-enhanced detection of heteronuclear multiple-bond connectivity by 2D multiple quantum NMR. J. Am. Chem. Soc., 108, 2093-2094.
30. Kumar, A., Ernst, R. R., Wuthrich, K. (1980). A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules. Biochem. Biophys. Res. Comms., 95, 1-6.
31. Clore,G. M., Gronenborn,A. M., Nilges, M., Ryan C. A. (1987). Three-dimensional structure of potato carboxypeptidase inhibitor in solution. A study using nuclear magnetic resonance, distance geometry, and restrained molecular dynamics. Biochemistry, 26, 8012-8023.
32. Bremser, W. (1978). HOSE-A novel substructure code. Anal. Chim. Acta., 103, 355-365.
33. Livingstone, D. (1995). Data Analysis for Chemists. Oxford University Press, New York.
34. Johnson, M., Maggiora, G. M. (1990). Concepts and Applications of Molecular Similarity. Wiley, New York.
35. Bishop, C. M. (1996). Neural Networks for Pattern Recognition. Oxford University Press, New York.
36. Shi, L. M., Fang, H.,Tong,W.,Wu, J., Perkins, R., M. Blair, R., Branham,W. S.,Dial, S. L., Moland, C. L., Sheehan, D. M. (2001). QSAR models using a large diverse set of estrogens, J. Chem. Inf. Comput. Sci., 41, 186-195.
37. Good, A. C., So, S. S., Richards,W. G. (1993). Structure-activity relationships from molecular similarity matrices. J. Med. Chem., 36, 433-438.
38. De Gregorio, C., Kier, L. B., Hall, L. H. (1988). QSAR modeling with electrotopological state indices: Corticosteroids. J. Comput.-Aided Mol. Design, 2, 557-561.
39. Beger, R. D., Buzatu, D.,Wilkes, J. G. (2002). Combining NMR spectral and structural data to form models of polychlorinated dibenzodioxins, dibenzofurans, and biphenyls binding to the AhR. J. Comput.-Aided Mol. Design, 16, 727-740.
40. Beger, R. D., Holm, K., Buzatu, D.,Wilkes, J. G. (2003). Using simulated 2D 13C-13C NMR spectral data to model a diverse set of estrogens. Internet Electronic J. Mol. Design, 2, 435-453.
41. Beger, R. D., Buzatu, D.,Wilkes, J. G., Lay, Jr., J. O. (2002). Developing comparative structural connectivity spectra analysis (CoSCoSA) models of steroid binding to the corticosteroid binding globulin. J. Chem. Inf. Comput. Sci., 42, 1123-1131.
42. Beger, R. D., Wilkes, J. G. (2002). Comparative structural connectivity spectra analysis (CoSCoSA) models of steroids binding to the aromatase enzyme. J. Mol. Recognition, 15, 154-162.
43. Blair, R. M., Fang, H., Branham,W. S., Hass, B. S., Dial, S. L., Moland, C. L., Tong, W., Shi, L., Perkins, R., Sheehan, D. M. (2000). The estrogen receptor relative binding affinities of 188 natural and xenochemicals: Structural diversity of ligands. Toxicol. Sci., 54, 138-153.
44. Branham,W. S., Dial, S. L., Moland, C. L., Hass, B. S., Blair, R. M., Fang, H., Shi, L., Tong, W., Perkins, R. G., Sheehan, D. M. (2002). Phytoestrogens and mycoestrogens bind to the rat uterine estrogen receptor, J. Nutr., 132, 658-664.
45. Bursi, R., Dao, T.,van Wilk, T., de Gooyer, M., Kellenbach, E., Verwer, P. (1999). Comparative spectra analysis (CoSA): Spectra as three-dimensional molecular descriptors for the prediction of biological activities. J. Chem. Inf. Comput. Sci., 39, 861-867.
46. Waller, C. L., Opera, T. I., Chae, K., Park, H. K., Korach, K. S., Laws, S. C.,Wiese, T. E., Kelce,W. R., Gray Jr., L. E. (1996). Ligand-based identification of environmental estrogens, Chem. Res. Toxicol., 9, 1240-1248.
47. Kuiper, G. G. J. M., Carlsson, B., Grandien, K., Enmark, E., Haggblad, J., Nilsson, S., Gustafsson, J.-A. (1997). Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors a and b. Endocrinology, 138, 863-870.
48. Fang, H., Tong, W., Perkins, R., Soto, A., Prechtl, N., Sheehan, D. M. (1998). Quantitative comparison of in vitro assays for estrogenic assays. Environ. Health Prospect., 139, 723-729.
49. Rumelhart, D. E., McClelland, T. L. (1986). Parallel Distributed Processing. Brandford Books/MIT Press, Cambridge, MA.
50. Jgravity, version 1.0 beta-1 build-10. Titan Systems, LinCom Division.
51. Devillers, J. (1996). Neural Networks in QSAR and Drug Design. Academic, New York.
52. Kellogg, G. E., Kier, L. B., Gaillard, P., Hall, L. H. (1996). E-state fields: Applications to 3D QSAR. J. Comput.-Aided Mol. Design, 10, 513-520.
53. Polanski, J. (1997). The receptor-like neural network for modeling corticosteroid and testosterone binding globulins. J. Chem. Inf. Comput. Sci., 37, 553-561.
54. Safe, S. (1990). Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs), dibenzofurans (PCDFs), and related compounds: Environmental and mechanistic considerations which support the development of toxic equivalency factors (TEFs). Crit. Rev. Toxicol., 21, 50-88.
55. Bhandiera, S., Sawyer, T., Romkes, M., Zmudzka, B., Safe, L., Mason, G., Keys, B., Safe, S. (1984). Polychlorinated dibenzofurans (PCDFs): Effects of structure on binding to the 2,3,7,8-TDDD cytosolic receptor protein, AHH induction and toxicity. Toxicology, 32, 131-144.
56. Bandiera, S., Safe, S., Okey,A. B. (1982). Binding of polychlorinated biphenyls classified as either phenobarbitone-, 3-methylcholanthrene-or mixed type inducers to cytosolic Ah receptor. Chem. Biol. Interact., 39, 259-277.
57. Poland, A., Knutson, J. C. (1982). 2,3,7,8-Tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: Examination of the mechanism of toxicity. Annu. Rev. Pharmacol. Toxicol., 22, 517-554.
58. Poland, A., Glover, E., Kende, A. S. (1976). Stereospecific, high affinity binding of 2,3,7,8-tetrachlorodibenzo-p-dioxin by hepatic cytosol: Evidence that the binding species is the receptor for induction of aryl hydrocarbon hydroxylase. J. Biol. Chem., 251, 493-494.
59. Safe, S. (1984). Polychlorinated biphenyls (PCBs) and polybrominated biphenyls (PBBs): Biochemistry, toxicology and mechanism of action. Crit. Rev. Toxicol., 13, 319-395.
60. Safe, S. H. (1986). Comparative toxicology and mechanism of action of polychlorinated dibenzo-p-dioxins and dibenzofurans. Annu. Rev. Pharmacol. Toxicol., 26, 371-399.
61. Mekemyan, O. G., Veith, G. D., Call, D. J., Ankley, G. T. (1996). A QSAR evaluation of Ah receptor binding of halogenated aromatic xenobiotics. Environ. Health Perspect., 104, 1302-1310.
62. Turner, D. B.,Willett, P., Ferguson, A. M., Heritage, T. (1997). Evaluation of novel infrared range vibration-based descriptor (EVA) for QSAR studies. 1. General application. J. Comput.-Aided Design, 11, 409-422.
63. Physicians' Desk Reference, 54th ed. (2000). Medical Economics Company, Montvale, NJ.
64. Joklik,W. K.,Willett, H. P.,Amos,D. B.,Wilfert, C. M. (1988). Zinsser Microbiolgy, 19th ed., pp. 128-160.
65. Grail, B. M., Payne, J. W. (2002). Conformational analysis of bacterial cell wall peptides indicates how particular conformations have influenced the evolution of penicillin-binding proteins, b-lactam antibiotics and antibiotic resistance mechanisms. J. Mol. Recognit., 15, 113-125.
66. Compadre, R. L. L., Pearlstein, R. A., Hopfinger, A. J., Seydel, J. K. (1987). A quantitative structure-activity relationship analysis of some 4-aminophenyl sulfone antibacterial agents using linear free energy and molecular modeling methods. J. Med. Chem., 30, 900-906.
67. Pickett, S. D., Sternberg, M. J. E. (1993). Empirical scale of side-chain conformational entropy in protein folding. J. Mol. Biol., 231, 825-839.
68. Karplus, M., Kushick, J. N. (1981). Method for estimating the configurational entropy of macromolecules. Macromolecules, 14, 325-332.